Although CNS-specific ORR, CR, and PR did not reach statistical significance, the data showed a strong trend favoring KGIs and a significant reduction in CNS progression as the best response.
← all excerpts
KRAS<sup>G12C</sup> inhibitors versus chemotherapy alone for KRAS<sup>G12C</sup>-mutated non-small cell lung cancer: a pooled analysis of CodeBreaK 200 and KRYSTAL-12 trials.
1
—
—